An insight into PI3k/Akt pathway and associated protein-protein interactions in metabolic syndrome: A recent update

J Cell Biochem. 2023 Jul;124(7):923-942. doi: 10.1002/jcb.30433. Epub 2023 Jul 6.

Abstract

Akt, a known serine/threonine-protein kinase B has been revealed to be an imperative protein of the PI3K/Akt pathway. Akt is available in three isoforms, Akt1, Akt2, and Akt3. Ubiquitously expressed Akt1 & Akt2 are essential for cell survival and are believed to be involved in regulating glucose homeostasis. PI3K/Akt pathway has been evidenced to be associated with metabolic diseases viz. hypertension, dyslipidemia, and diabetes. Akt interacting proteins have been revealed to be scaffold proteins of the PI3K/Akt pathway. Notably, some protein-protein interactions are imperative for the inhibition or uncontrolled activation of these signaling pathways. For instance, Akt interacting protein binds with other protein namely, FOXO1 and mTOR, and play a key role in the onset and progression of metabolic syndrome (MS). The purpose of this review is to highlight the role of the PI3K/Akt pathway and associated protein-protein interactions which might serve as a valuable tool for investigators to develop some new promising therapeutic agents in the management of MS.

Keywords: Akt/PI3K signaling; metabolic diseases; microRNAs; protein-protein interactions; serine/threonine-protein kinase.

Publication types

  • Review

MeSH terms

  • Humans
  • Metabolic Syndrome*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein Isoforms / metabolism
  • Proto-Oncogene Proteins c-akt* / metabolism
  • Signal Transduction

Substances

  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases
  • Protein Isoforms